Skip to main content
. 2020 May 4;100(9):1197–1207. doi: 10.1038/s41374-020-0436-1

Fig. 5. Overexpression of MANF by AAV9 enhances β cell proliferation in a mouse model of Wolfram syndrome.

Fig. 5

a Top panels: double immunofluorescence staining of insulin (green fluorescence) and MANF (red fluorescence) on pancreatic tissue sections from β cell-specific Wfs1 knockout mice (βWfs1(−/−)) taken 5 weeks after intraperitoneal injection of AAV-control (AAV9-CBA-IRES-GFP) or AAV9-MANF (AAV9-CBA-MANF-IRES-GFP) vector (n = 6 each group). Middle panels: double immunofluorescence staining of insulin (green fluorescence) and Ki67 (red fluorescence) of pancreatic sections from βWfs1(−/−) mice taken 5 weeks after intraperitoneal injection of AAV-control or AAV9-MANF vector (n = 6 in each group). Bottom panels: double immunofluorescence staining of insulin (green fluorescence) and TUNEL staining (red fluorescence) of pancreatic sections from βWfs1(−/−) mice taken 5 weeks after intraperitoneal injection of AAV-control or AAV9-MANF vector (n = 6 each group). The magnification is ×10 for each image, and ×40 for the right upper images. b Quantification of Ki67-positive β cells in AAV-control or AAV9-MANF injected βWfs1(−/−) mice (AAV-control, n = 5; AAV9-MANF, n = 6; *P < 0.05). c Quantification of β cell mass in AAV-control or AAV9-MANF injected βWfs1(−/−) mice (n = 6 in each group, not significant).